Antithrombin III deficiency: Difference between revisions
Jump to navigation
Jump to search
m Robot: Changing Category:Disease state to Category:Disease |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 38: | Line 38: | ||
{{Hematology}} | {{Hematology}} | ||
[[pt:Deficiência de antitrombina III]] | [[pt:Deficiência de antitrombina III]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} |
Revision as of 22:21, 8 August 2012
For patient information click here
Antithrombin III deficiency | |
ICD-9 | 289.81 |
---|---|
OMIM | 107300 |
DiseasesDB | 783 |
MeSH | D020152 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antithrombin III deficiency is a rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism.
This was first described by Egeberg in 1965.[1]
The patients are treated with anticoagulants or, more rarely, with antithrombin concentrate.
In renal failure, especially nephrotic syndrome, antithrombin is lost in the urine, leading to a higher activity of Factor II and Factor X and in increased tendency to thrombosis.
See also
References
- ↑ Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516–520. PMID 14347873.